bpc 157 inflammatory bowel disease human study BPC-157 & The Gut-Brain Axis: A Practitioner's Definitive Review of the Evidence Frontiers | Stable Gastric Pentadecapeptide
Description
Vollset SE, Clarke R, Lewington S, Ebbing M, Halsey J, Lonn E, et al
For semaglutide, with a half-life of approximately one week, this means a 5-7 week gap
While marketed as an anti-aging therapy, more robust studies are needed to validate these claims
Over time, that deficit adds up
